Table 2 Univariate analysis

Age

1.011

0.914–1.119

0.830

0.985

0.917–1.058

0.675

BMI

1.138

0.932–1.389

0.206

0.979

0.848–1.131

0.772

Hypertension

1.815

0.555–5.931

0.324

1.298

0.525–3.207

0.572

Diabetes Mellitus

1.333

0.343–5.178

0.678

0.700

0.226–2.166

0.536

MetS

1.818

0.483–6.850

0.377

1.300

0.492–3.434

0.597

Total-PSA (ng/ml)

1.013

0.964–1.064

0.618

1.004

0.986–1.023

0.645

Free-PSA (ng/ml)

1.180

0.737–1.888

0.491

1.249

0.884–1.765

0.208

PSA

 PSA ≤ 4

1.286

0.213–7.760

0.784

NA

NA

NA

 PSA > 4

Ref

Ref

Ref

Ref

Ref

Ref

Free PSA/Total PSA ratio

 ≤ 18%

Ref

Ref

Ref

Ref

Ref

Ref

 > 18%

1.462

0.372–5.751

0.586

0.581

0.090–3.738

0.567

PV (ml)

1.001

0.986–1.017

0.904

0.991

0.978–1.005

0.192

PI-RADS

 ≤ 3

0.524

0.167–1.638

0.266

1.136

0.437–2.957

0.793

 > 3

Ref

Ref

Ref

Ref

Ref

Ref

Number of biopsy cores

1.295

0.372–4.515

0.685

0.942

0.824–1.077

0.381

Rate of positive cores in biopsy

5.455

0.126–236.209

0.378

8.214

0.837–80.569

0.071

Clinical stage

 T1

Ref

Ref

Ref

Ref

Ref

Ref

 T2

3.375

0.283–40.254

0.336

2.200

0.190–25.516

0.528

 T3

4.000

0.211–75.659

0.355

5.333

0.343–82.827

0.232

Triglyceride

0.955

0.684–1.333

0.786

1.082

0.639–1.832

0.770

HDL-C

1.446

0.216–9.666

0.704

7.735

0.998–59.957

0.050

Lymphocyte counts

0.789

0.359–1.736

0.557

1.261

0.703–2.262

0.437

Percentage of lymphocyte (%)

0.951

0.904–1.000

0.052

0.995

0.959–1.032

0.780

Neutrophile counts

1.326

1.005–1.748

0.046

1.114

0.967–1.283

0.134

Percentage of neutrophile

1.022

0.985–1.059

0.248

0.989

0.962–1.017

0.450

NLR

1.128

0.980–1.297

0.092

1.013

0.972–1.056

0.532

Hb

0.964

0.923–1.007

0.101

0.983

0.956–1.012

0.248